|
1
|
Yamamoto M, Sakaguchi Y, Matsuyama A,
Yoshinaga K, Tsutsui S and Ishida T: Surgery after preoperative
chemotherapy for patients with unresectable advanced gastric
cancer. Oncology. 85:241–247. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Qiu HB, Zhang LY, Keshari RP, Wang GQ,
Zhou ZW, Xu DZ, Wang W, Zhan YQ and Li W: Relationship between H.
Pylori infection and clinicopathological features and prognosis of
gastric cancer. BMC Cancer. 10:3742010. View Article : Google Scholar
|
|
3
|
Lu Y, Zhang X, Zhang H, Lan J, Huang G,
Varin E, Lincet H, Poulain L and Icard P: Citrate induces apoptotic
cell death: a promising way for treating gastric carcinoma?
Anticancer Res. 31:797–805. 2011.PubMed/NCBI
|
|
4
|
Grosse J, Warnke E, Wehland M, Pietsch J,
Pohl F, Wise P, Magnusson NE, Eilles C and Grimm D: Mechanisms of
apoptosis in irradiated and sunitinib-treated follicular thyroid
cancer cells. Apoptosis. 19:480–490. 2014. View Article : Google Scholar
|
|
5
|
Tokumoto M, Lee JY, Fujiwara Y, Uchiyama M
and Satoh M: Inorganic arsenic induces apoptosis through
downregulation of Ube2d genes and p53 accumulation in rat proximal
tubular cells. J Toxicol Sci. 38:815–820. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Nguyen QD, Lavdas I, Gubbins J, Smith G,
Fortt R, Carroll LS, Graham MA and Aboagye EO: Temporal and spatial
evolution of therapy-induced tumor apoptosis detected by
caspase-3-selective molecular imaging. Clin Cancer Res.
19:3914–3924. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Rahman KM, Banerjee S, Ali S, Ahmad A,
Wang Z, Kong D and Sakr WA: 3,3′-Diindolylmethane enhances
taxotere-induced apoptosis in hormone-refractory prostate cancer
cells through survivin down-regulation. Cancer Res. 69:4468–4475.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Liu L, Gong L, Zhang Y and Li N:
Glycolysis in Panc-1 human pancreatic cancer cells is inhibited by
everolimus. Exp Ther Med. 5:338–342. 2013.
|
|
9
|
Khatri S, Yepiskoposyan H, Gallo CA,
Tandon P and Plas DR: FOXO3a regulates glycolysis via
transcriptional control of tumor suppressor TSC1. J Biol Chem.
285:15960–15965. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Floridi A, Paggi MG and Fanciulli M:
Modulation of glycolysis in neuroepithelial tumors. J Neurosurg
Sci. 33:55–64. 1989.PubMed/NCBI
|
|
11
|
Nwagwu M and Opperdoes FR: Regulation of
glycolysis in Trypanosoma brucei: hexokinase and
phosphofructokinase activity. Acta Trop. 39:61–72. 1982.PubMed/NCBI
|
|
12
|
El Sayed SM, Mahmoud AA, El Sawy SA,
Abdelaal EA, Fouad AM, Yousif RS, Hashim MS, Hemdan SB, Kadry ZM,
Abdelmoaty MA, Gabr AG, Omran FM, Nabo MM and Ahmed NS: Warburg
effect increases steady-state ROS condition in cancer cells through
decreasing their antioxidant capacities (anticancer effects of
3-bromopyruvate through antagonizing Warburg effect). Med
Hypotheses. 81:866–870. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Cardaci S, Desideri E and Ciriolo MR:
Targeting aerobic glycolysis: 3-bromopyruvate as a promising
anticancer drug. J Bioenerg Biomembr. 44:17–29. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ganapathy-Kanniappan S, Vali M,
Kunjithapatham R, Buijs M, Syed LH, Rao PP, Ota S, Kwak BK, Loffroy
R and Geschwind JF: 3-bromopyruvate: a new targeted antiglycolytic
agent and a promise for cancer therapy. Curr Pharm Biotechnol.
11:510–517. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Xian SL, Wei C and Lu YF: 3-BrPA inhibits
proliferation of human gastric cancer cell. Chin Pract Med J.
12:78–82. 2013.(In Chinese).
|
|
16
|
Geschwind JF, Ko YH, Torbenson MS, Magee C
and Pedersen PL: Novel therapy for liver cancer: direct
intraarterial injection of a potent inhibitor of ATP production.
Cancer Res. 62:3909–3913. 2002.PubMed/NCBI
|
|
17
|
Liapi E and Geschwind JF: Interventional
oncology: new options for interstitial treatments and intravascular
approaches: targeting tumor metabolism via a loco-regional
approach: a new therapy against liver cancer. J Hepatobiliary
Pancreat Sci. 17:405–406. 2010. View Article : Google Scholar
|
|
18
|
Liu XH, Zheng XF and Wang YL: Inhibitive
effect of 3-bromopyruvic acid on human breast cancer MCF-7 cells
involves cell cycle arrest and apoptotic induction. Chin Med J
(Engl). 122:1681–1685. 2009.
|
|
19
|
Ota S, Geschwind JF, Buijs M, Wijlemans
JW, Kwak BK and Ganapathy-Kanniappan S: Ultrasound-guided direct
delivery of 3-bromopyruvate blocks tumor progression in an
orthotopic mouse model of human pancreatic cancer. Target Oncol.
8:145–151. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Xu J, Wang J, Xu B, Ge H, Zhou X and Fang
JY: Colorectal cancer cells refractory to anti-VEGF treatment are
vulnerable to glycolytic blockade due to persistent impairment of
mitochondria. Mol Cancer Ther. 12:717–724. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Danial NN, Gramm CF, Scorrano L, et al:
BAD and glucokinase reside in a mitochondrial complex that
integrates glycolysis and apoptosis. Nature. 424:952–956. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Nelson K: 3-Bromopyruvate kills cancer
cells in animals. Lancet Oncol. 3:5242002. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Cali U, Cavkaytar S, Sirvan L and Danisman
N: Placental apoptosis in preeclampsia, intrauterine growth
retardation, and HELLP syndrome: an immunohistochemical study with
caspase-3 and bcl-2. Clin Exp Obstet Gynecol. 40:45–48.
2013.PubMed/NCBI
|
|
24
|
Han CR, Jun do Y, Lee JY and Kim YH:
Prometaphase arrest-dependent phosphorylation of Bcl-2 and Bim
reduces the association of Bcl-2 with Bak or Bim, provoking Bak
activation and mitochondrial apoptosis in nocodazole-treated Jurkat
T cells. Apoptosis. 19:224–240. 2014. View Article : Google Scholar
|
|
25
|
Doudican N, Rodriguez A, Osman I and Orlow
SJ: Mebendazole induces apoptosis via Bcl-2 inactivation in
chemoresistant melanoma cells. Mol Cancer Res. 6:1308–1315. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Deyhimi P and Tavakoli P: Study of
apoptosis in oral pemphigus vulgaris using immunohistochemical
marker Bax and TUNEL technique. J Oral Pathol Med. 42:409–414.
2013. View Article : Google Scholar
|
|
27
|
Banadyga L, Veugelers K, Campbell S and
Barry M: The fowlpox virus BCL-2 homologue, FPV039, interacts with
activated Bax and a discrete subset of BH3-only proteins to inhibit
apoptosis. J Virol. 83:7085–7098. 2009. View Article : Google Scholar : PubMed/NCBI
|
